The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 735-740

  Barber, Linda D ^a,f   Percival, Lucy ^a   Valiante, Nicholas M ^a,g   Chen, Ling ^b   Lee, Christopher ^a   Gumperz, Jenny E ^a   Phillips, Joseph H ^c   Lanier, Lewis L ^c   Bigge, Judith C ^d   Parekh, Raj B ^d   Parham, Peter ^a,e  

^a STANFORD UNIVERSITY   (United States)

^b APPLIED BIOSYSTEMS   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Oxford GlycoSystems Ltd   (United Kingdom)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AMERICAN HEART ASSOCIATION   (United States)

^g Cancer Res Institute of New York

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA C ANTIGEN;

ARTICLE; CANCER RISK; GENE LOCUS; GENETIC RECOMBINATION; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL;

EID: 10144247246     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.735     Document Type: Article

References (28)

1. Parham, P., E.J. Adams, and K.L. Arnett. 1995. The origins of HLA-A,B,C polymorphism. Immunol. Rev. 143:141-180.
2. Zemmour, J., and P. Parham. 1992. Distinct polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J. Exp. Med. 176:937-950.
3. McCutcheon, J. A., J.E. Gumperz, K.D. Smith, C.T. Lutz, and P. Parham. 1995. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181:2085-2095.
4. Zemmour, J., J.E. Gumperz, W.H. Hildebrand, F.E. Ward, S.G.E. Marsh, R.C. Williams, and P. Parham. 1992. The molecular basis for reactivity of anti Cw1 and anti Cw3 alloantisera with HLA-B46 haplotypes. Tissue Antigens. 39: 249-257.
5. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobori. 1992. W15.1: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol. 1. K. Tsuji, M. Aizawa, and T. Sasasuki, editors. Oxford Science Publications, Oxford University Press, Oxford, UK. 1065-1220.
6. Simons, M.J., G.B. Wee, S.H. Chan, and K. Shanmugaratnam. 1975. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet. 1:142-143.
7. Chan, S.H., N.E. Day, N. Kunaratnam, K.B. Chia, and M.J. Simons. 1983. HLA and nasopharyngeal carcinoma in Chinese - a further study. Int. J. Cancer. 32:171-176.
8. Chan, S.H., C.B. Tan, Y.N. Lin, G.B. Wee, M.A. Degli-Esposti, and R.L. Dawkins. 1993. HLA and Singaporean Chinese myasthenia gravis. Int. Arch. Allergy Immunol. 101:119-125.
9. Chan, S.H., P.P.B. Yeo, K.F. Lui, G.B. Wee, K.T. Woo, P. Lim, and J.S. Cheah. 1978. HLA and thyrotoxicosis (Graves' disease) in Chinese. Tissue Antigens. 12:109-114.
10. Hawkins, B.R., J.T.C. Ma, K.S.L. Lam, C.C.L. Wang, and R.T.T. Yeung. 1985. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin. Endocrinol. 23:245-252.
11. Naito, S., H. Sasaki, and K. Arakawa. 1987. Japanese Graves' disease: association with HLA-Bw46. Endocrinol. Jpn. 34: 685-688.
12. Onuma, H., M. Ota, A. Sugenoya, and H. Inoko. 1994. Association of HLA-DPB1*0501 with early onset Graves' disease in Japanese. Human Immunol. 39:195-201.
13. Baur, M.P., M. Neugebauer, and E.D. Albert. 1984. Reference tables for two-locus haplotype frequencies for all MHC marker loci. In Histocompatibility Testing. Springer-Verlag, Berlin. 677 pp.
14. Gumperz, J.E., V. Litwin, J.H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181:1133-1144.
15. Barber, L.D., B. Gillece-Castro, L. Percival, X. Li, C. Clayberger, and P. Parham. 1995. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 5:179-190.
16. Barnstable, C.J., W.F. Bodmer, G. Brown, G. Galfre, C. Milstein, A.F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis Cell. 14:9-20.
17. Lee, C., and M. Levitt. 1991. Accurate prediction of the stability and activity effects of site-directed mutagenesis on a protein core. Nature (Lond.). 352:448-451.
18. Lee, C. 1994. Predicting protein mutant energetics by self-consistent ensemble optimization. J. Mol. Biol. 236:918-939.
19. Madden, D.R., D.N. Garboczi, and D.C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 75:693-708.
20. Barber, L.D., T.P. Patel, L. Percival, J.E. Gumperz, L.L. Lanier, J.H. Phillips, J.C. Bigge, M.R. Wormald, R.B. Parekh, and P. Parham. 1996. Unusual uniformity of the N-linked oligosaccharides of HLA-A,B and C glycoproteins. J. Immunol. 156:3275-3284.
21. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanovic, V. Gnau, G. Jung, J.L. Strominger, and H-G Rammensee. 1993. Allele-specific peptide ligand motifs for HLA-C molecules. Proc. Natl. Acad. Sci. USA. 90:12005-12009.
22. Tanahashi, N., C. Tsurumi, T. Tamura, and K. Tanaka. 1993. Molecular structures of 20S and 26S proteasomes. Enzyme Protein. 47:241-251.
23. Dworniczak, B., and M-E. Mirault. 1987. Structure and expression of a human gene coding for a 71 kd heat shock 'cognate' protein. Nuc. Acid Res. 15:5181-5197.
24. Colonna, M., G. Borsellino, M. Falco, G.B. Ferrara, and J.L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA. 90:12000-12004.
25. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182:605-609.
26. Ishikawa, Y., K. Tokunaga, H. Tanaka, M. Nishimura, M. Muraoka, Y. Fujii, T. Akaza, K. Tadokoro, and T. Juji. 1995. HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult. Immunogenetics. 43:1-5.
27. Liebowitz, D. 1994. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin. Oncol. 21:376-381.
28. Chen, Y., and S.H. Chan. 1994. Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int. J. Cancer. 56: 830-833.